000153.SZ · 丰原药业
China A-shares · RS rating 76 · As of 2026-10-14
| Price | 5.95 CNY |
|---|---|
| 1-day change | -0.2% |
| RS rating (overall / 1M / 3M / 12M) | 76 / 53 / 82 / 60 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 28 / 37 / 30 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -0.1% |
| Distance from 52-week high | +15.4% |
| Market cap (USD) | $428.1M |